The budget impact of introducing the OMNI ® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma

CONCLUSION: OMNI® is budgetary efficient from a US payer perspective.PMID:37224422 | DOI:10.1080/14737167.2023.2217357

Source: Expert Review of Pharmacoeconomics and Outcomes Research - May 24, 2023 Category: Health Management Authors: Gregory Mader Federico Ghinelli Francesca Torelli Chad Patel Cristina Masseria Jaime Dickerson Dan Nguyen Louis Cantor Source Type: research